Related Experiment Video
Updated: Jun 25, 2026

The Galleria mellonella Waxworm Infection Model for Disseminated Candidiasis
Published on: November 17, 2018
Fungemia With Wickerhamomyces anomalus: A Case Report and Literature Review
Yui Sakai1, Toshibumi Taniguchi2, Yoriko Herai2,3
1Infectious Diseases, Chiba University School of Medicine, Chiba, JPN.
Abstract:
We report the case of an 84-year-old man with a history of IgG4-related sclerosing cholangitis who was diagnosed with advanced esophageal cancer and underwent radiation and chemotherapy. An implantable central venous access port was placed for chemotherapy and total parenteral nutrition. The patient presented with a fever and received antimicrobial therapy for acute cholangitis but remained febrile, and subsequently, yeast was detected in the aerobic bottle of blood culture obtained from the central venous line. The yeast was identified as Wickerhamomyces anomalus. Liposomal amphotericin B was administered, and the central line access port was removed. After confirmation of negative blood cultures and 14 days post treatment, he underwent reinsertion of the central line access port. Due to persistent pain at the insertion site, fluconazole was added for an additional 14 days, and the patient was discharged and transferred to another hospital. Wickerhamomyces anomalus is a rare fungal infection with other synonyms including Pichia anomala, Hansenula anomala, and Candida pelliculosa. A literature review of 53 case reports of Wickerhamomyces anomalus, Pichia anomala, Hansenula anomala, and Candida pelliculosa was conducted, with a total of 211 cases reviewed. Fungemia was reported in 94% of cases, with central venous catheterization, parental feeding, low birth weight, and immunocompromised status identified as major risk factors. The majority of cases were pediatric, particularly neonatal, and there were reports of nosocomial infections causing outbreaks, with some cases involving the eye such as endophthalmitis or keratitis.
Insights
This case highlights a rare fungal infection, Wickerhamomyces anomalus, in an elderly patient undergoing cancer treatment. Early detection and treatment are crucial for managing fungemia associated with central venous catheters.
Area of Science:
- Infectious Diseases
- Mycology
- Oncology
Background:
- IgG4-related sclerosing cholangitis and advanced esophageal cancer can necessitate invasive procedures like central venous catheterization.
- Central venous access ports are vital for long-term therapies such as chemotherapy and total parenteral nutrition.
Observation:
- An 84-year-old male patient developed fever and fungemia due to Wickerhamomyces anomalus after central venous port placement.
- The yeast was identified in blood cultures from the central venous line, indicating a catheter-related bloodstream infection.
Findings:
- Wickerhamomyces anomalus fungemia is rare, with central venous catheterization and immunocompromised status being significant risk factors.
- A literature review identified fungemia in 94% of W. anomalus cases, predominantly in pediatric and neonatal populations.
Implications:
- This case underscores the importance of vigilance for rare fungal pathogens in immunocompromised patients with central venous catheters.
- Prompt diagnosis, appropriate antifungal therapy (liposomal amphotericin B, fluconazole), and device removal/management are critical for successful outcomes.
Related Concept Videos
Overview of Fungi
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Fungal Phylum Ascomycota
Cryptococcal Meningitis
Candidiasis

